| Schlüsselwörter:
Krankheit, Therapie, Behandlung, Medikament,
Chemotherapie, Chemotherapie, Trastuzumab, Herceptin,
lokoregionales Karzinom, Studie B-31 des National Surgical Adjuvant
Breast and Bowel Project (NSABP) und Studie N9831 der North Central
Cancer Treatment Group (NCCTG). |